NASDAQ:ZNTL

A year in review: Zentalis Pharmaceuticals Inc (ZNTL)’s performance in the last year
Arcelia Reed
While Zentalis Pharmaceuticals Inc has underperformed by -1.43%, investors are advised to look at stock chart patterns for technical insight. ...





